Pemetrexed for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer.

The research reported in this article of the journal supplement was commissioned and funded by the HTA programme on behalf of NICE as project number 08/207/01. The assessment report began editorial review in November 2009 and was accepted for publication in February 2010. See the HTA programme website for further project information (www.hta.ac.uk). This summary of the ERG report was compiled after the Appraisal Committee’s review.